HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunogenic cell death modalities and their impact on cancer treatment.

Abstract
It is still enigmatic under which circumstances cellular demise induces an immune response or rather remains immunologically silent. Moreover, the question remains open under which circumstances apoptotic, autophagic or necrotic cells are immunogenic or tolerogenic. Although apoptosis appears to be morphologically homogenous, recent evidence suggests that the pre-apoptotic surface-exposure of calreticulin may dictate the immune response to tumor cells that succumb to anticancer treatments. Moreover, the release of high-mobility group box 1 (HMGB1) during late apoptosis and secondary necrosis contributes to efficient antigen presentation and cytotoxic T-cell activation because HMGB1 can bind to Toll like receptor 4 on dendritic cells, thereby stimulating optimal antigen processing. Cell death accompanied by autophagy also may facilitate cross priming events. Apoptosis, necrosis and autophagy are closely intertwined processes. Often, cells manifest autophagy before they undergo apoptosis or necrosis, and apoptosis is generally followed by secondary necrosis. Whereas apoptosis and necrosis irreversibly lead to cell death, autophagy can clear cells from stress factors and thus facilitate cellular survival. We surmise that the response to cellular stress like chemotherapy or ionizing irradiation, dictates the immunological response to dying cells and that this immune response in turn determines the clinical outcome of anticancer therapies. The purpose of this review is to summarize recent insights into the immunogenicity of dying tumor cells as a function of the cell death modality.
AuthorsOliver Kepp, Antoine Tesniere, Frederic Schlemmer, Mickael Michaud, Laura Senovilla, Laurence Zitvogel, Guido Kroemer
JournalApoptosis : an international journal on programmed cell death (Apoptosis) Vol. 14 Issue 4 Pg. 364-75 (Apr 2009) ISSN: 1573-675X [Electronic] Netherlands
PMID19145485 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Calreticulin
Topics
  • Animals
  • Apoptosis (immunology)
  • Autophagy
  • Calreticulin (immunology)
  • Cell Death (immunology)
  • Humans
  • Immunity (immunology)
  • Models, Biological
  • Necrosis
  • Neoplasms (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: